Epratuzumab

From Wikipedia, the free encyclopedia
Epratuzumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target CD22
Clinical data
Legal status ?
Identifiers
CAS number 205923-57-5 N
ATC code None
UNII 3062P60MH9 YesY
KEGG D04036 YesY
Chemical data
Formula ?
 N (what is this?)  (verify)

Epratuzumab is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as lupus (SLE).[1][2] The manufacturers in August 2009 announced success in early trials against SLE.[3]

Mechanism

Epratuzumab binds to the glycoprotein CD22 of mature and malignant B-cells.

See also

External links


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.